Loading chart...





The current price of SLBT is 0 USD — it has increased 0
SL Science Holding Ltd is a Taiwan-based company mainly engaged in the research and development (R&D) of cell and gene therapies for cancer treatment and regenerative medicine. The Company develops investigational immune cell technologies, including gamma delta (γδ) T cells, Armed-T cells and exosome-based formulations, and operates through its biotechnology and oncology research activities.
Wall Street analysts forecast SLBT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SLBT is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
SL Science Holding Ltd revenue for the last quarter amounts to NaN USD, decreased
SL Science Holding Ltd. EPS for the last quarter amounts to USD, decreased
SL Science Holding Ltd (SLBT) has 0 emplpoyees as of June 13 2026.
Today SLBT has the market capitalization of 0.00 USD.